2021 ABioM SIG Meeting

Updated information: BMES will co-locate the ABioM and the Frontiers in Medical Devices conferences in March 2021. 
Due to increased concerns regarding COVID-19 (Coronavirus) and resulting travel restrictions, BMES and the conference organizing committee have elected to postpone ABioM until March 2021.

More information is forthcoming.

If you are a speaker, and/or you have an accepted abstract, you will be contacted shortly to determine your availability for the new dates.

If you have already registered, you will receive a full refund.

Thank you for your patience and support. These are unsettled and challenging times for us all and we deeply appreciate your patience and support.

If you have any further questions, please contact membership@bmes.org

2020 ABioM SIG Annual Meeting

"Accelerating Advanced Biomanufacturing through Discovery to Translation"

The overarching goal of 2020 ABioM SIG Meeting is to celebrate the success of the field and to stimulate collaborations and promote R&D and education programs in advanced biomanufacturing by identifying gaps and challenges in the field. The conference will draw upon our past successes in launching the first and second meetings. The field has witnessed many breakthroughs including 3D bioprinting, biomaterial genome, machine learning, organoid development and fabrication in the last several years. The rapid growth of biomanufacturing industries and education programs offers new opportunities to spur research, education, industry growth and innovation in the field.  The conference uniquely positions itself to highlight the integration of academic forces with industry niches to accelerate the translation of lab discoveries into products in the industry. Unlike other conferences, this meeting brings together policymakers, scientists, engineers, and entrepreneurs as well as educators to map the field and identify the grant challenges and opportunities in the field.  It also offers a unique platform allowing junior investigators and students to interact with leaders in the field to evoke productive collaborations and partnerships.

We expect to assemble heads of biomanufacturing corporations, leaders from national labs, program directors from federal and state funding agencies and private foundations, leaders of industry/academic biomanufacturing initiatives, manufacturers of clinical cell and tissue therapies, innovators of next-generation approaches, and directors of related workforce training initiatives to participate in a highly interactive program. We expect to achieve the following objectives through the conference:

  • To identify new collaboration opportunities between academia and industry
  • To grow and sustain advanced biomanufacturing industries and research programs
  • To form a community to share ideas, resources, and technologies
  • To introduce junior investigators to research leaders and encourage interactions
  • To expose students to exciting research at the cutting edge of advanced biomanufacturing and regulatory sciences